Proceedings of the 2017 2nd International Conference on Biological Sciences and Technology (BST 2017)

(E)-3-(dimethylamino)-1-(1H-indol-3-yl)prop-2-en-1-one

Authors
Wen-Sheng Zou, Li-Wen Jiang, Shuang Jia, Wu-Fu Zhu
Corresponding Author
Wen-Sheng Zou
Available Online February 2018.
DOI
10.2991/bst-17.2018.38How to use a DOI?
Keywords
(E) -3- (dimethylamino) -1- (1H-indol-3-yl) prop-2-en-1-on, Synthesis
Abstract

(E) -3- (dimethylamino) -1- (1H-indol-3-yl) prop-2-en-1-one (4) is an important intermediate in many biologically active compounds such as osimertinib. In this work, compound (4) was synthesized through three steps, using 1H-indole as starting material. The synthetic method of 4 was optimized and can be used to synthesize the derivatives of (E) -3- (dimethylamino) -1- (1H-indol-3-yl) prop-2-en-1-on. And the structure of (E)-3- (dimethylamino) -1-(1H-indol-3-yl) prop-2-en-1-one is confirmed by MS and 1HNMR spectrum.

Copyright
© 2018, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

Volume Title
Proceedings of the 2017 2nd International Conference on Biological Sciences and Technology (BST 2017)
Series
Advances in Biological Sciences Research
Publication Date
February 2018
ISBN
10.2991/bst-17.2018.38
ISSN
2468-5747
DOI
10.2991/bst-17.2018.38How to use a DOI?
Copyright
© 2018, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

TY  - CONF
AU  - Wen-Sheng Zou
AU  - Li-Wen Jiang
AU  - Shuang Jia
AU  - Wu-Fu Zhu
PY  - 2018/02
DA  - 2018/02
TI  - (E)-3-(dimethylamino)-1-(1H-indol-3-yl)prop-2-en-1-one
BT  - Proceedings of the 2017 2nd International Conference on Biological Sciences and Technology (BST 2017)
PB  - Atlantis Press
SP  - 251
EP  - 254
SN  - 2468-5747
UR  - https://doi.org/10.2991/bst-17.2018.38
DO  - 10.2991/bst-17.2018.38
ID  - Zou2018/02
ER  -